Results 91 to 100 of about 1,312,052 (154)

Tumor necrosis factor α Inhibition for Alzheimer’s Disease

open access: yesJournal of Central Nervous System Disease, 2017
Tumor necrosis factor α (TNF-α) plays a central role in the pathophysiology of Alzheimer’s disease (AD). Food and Drug Administration–approved biologic TNF-α inhibitors are thus a potential treatment for AD, but they do not cross the blood-brain barrier.
Rudy Chang   +2 more
doaj   +1 more source

Risk of disseminated tuberculosis and other infections after neonatal Bacillus Calmette–Guérin vaccination in infants with in-utero exposure to tumor necrosis factor-α inhibitors

open access: yesFrontiers in Medicine
IntroductionInfants born to mothers with autoimmune rheumatic diseases, including rheumatoid arthritis, spondyloarthropathy, and inflammatory bowel disease, may be exposed antenatally to tumor necrosis factor-alpha (TNF-α) inhibitors.
Samar Al Emadi   +6 more
doaj   +1 more source

Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al

open access: yes, 2019
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et ...
Giollo, Alessandro   +5 more
core   +1 more source

Association analysis between TRAF3IP2, STAT4, PSORS1C1 and PTPN2 polymorphisms and response to TNF-inhibitors treatment in RA patients.

open access: yes, 2017
Association analysis between TRAF3IP2, STAT4, PSORS1C1 and PTPN2 polymorphisms and response to TNF-inhibitors treatment in RA patients.
Paola Borgiani (424003)   +10 more
core   +1 more source

TNF Inhibitors and Uveitis in Ankylosing Spondylitis

open access: yes, 2009
Uveitis is the most common extra-articular manifestation of ankylosing spondylitis, and this occurs in 30 50% of the patients with ankylosing spondylitis.
���������
core  

Association of the TNF-alpha G-308A polymorphism with TNF-inhibitor response in sarcoidosis

open access: yes, 2014
Item does not contain fulltextResponsiveness to tumour necrosis factor (TNF) inhibitors has been associated with the TNF-alpha G-308A polymorphism in rheumatoid arthritis.
Wijnen, P.A.   +7 more
core   +1 more source

Pharmacodynamics of TNF-α inhibitors in psoriasis

open access: yes, 2011
Over the last two decades, research developments have revolutionized our understanding of the pathogenesis of psoriasis and of the contribution of several cytokines in the manifestation of the disease.
Stratigos, A.J.   +4 more
core   +1 more source

Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review

open access: yesVascular Health and Risk Management
Hitaishi Mehta,1 Tarun Narang,1 Sunil Dogra,1 Sanjeev Handa,1 Juniali Hatwal,2 Akash Batta3 1Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India; 2Department of ...
Mehta H   +5 more
doaj  

Differential regulation of SOCS signalling and immunoproteasome pathways by JAK inhibitors and TNF inhibitors in rheumatoid arthritis. [PDF]

open access: yesArthritis Res Ther
Ghannam K   +10 more
europepmc   +1 more source

TNF-inhibitors for rheumatic diseases (part 3): Health economics

open access: yes, 2007
Behandling med tumor nekrose faktor alfa (TNF-α eller bare TNF)-hemmere blir ansett som et alternativ til behandling med tradisjonelle sykdomsmodifiserende antirevmatiske medikamenter (såkalte DMARDs) for pasienter med revmatiske lidelser som revmatoid ...
Movik, Espen   +2 more
core  

Home - About - Disclaimer - Privacy